VisionPoint Advisory Group Portfolio holdings
Top Buys
Top Sells
| 1 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$4.15M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$2.67M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.65M |
| 4 |
Regan Floating Rate MBS ETF
MBSF
|
+$1.8M |
| 5 |
Fresenius Medical Care
FMS
|
+$1.71M |
Sector Composition
| 1 | Technology | 11.71% |
| 2 | Financials | 7.14% |
| 3 | Healthcare | 5.97% |
| 4 | Industrials | 4.73% |
| 5 | Communication Services | 4.09% |
Similar funds
VisionPoint Advisory Group's Q2 2025 Portfolio in Review
As of Q2 2025, VisionPoint Advisory Group held 376 positions worth $460M, up 58% from $292M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
VisionPoint Advisory Group deployed $142M of net new capital in Q2 2025, opening 171 new positions and adding to 131 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 25,753 shares worth $4.68M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, an estimated $4.15M trimmed.
- VisionPoint Advisory Group's largest Q2 2025 buy was Invesco S&P 500 Equal Weight ETF: 25,753 shares worth $4.68M.
- VisionPoint Advisory Group added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2025, an estimated $5.72M increase.
- VisionPoint Advisory Group's biggest Q2 2025 reduction was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, cutting an estimated $4.15M.
- VisionPoint Advisory Group fully exited iShares US Medical Devices ETF in Q2 2025, selling an estimated $2.67M.
- VisionPoint Advisory Group's ten largest holdings make up 22% of its $460M portfolio in Q2 2025.
- VisionPoint Advisory Group opened 171 new positions and closed 18 in Q2 2025.
- VisionPoint Advisory Group's portfolio value rose 58% quarter-over-quarter to $460M.
Based on VisionPoint Advisory Group's 13F filing for Q2 2025, filed 9 Jul 2025.